Physician

Chirag C Patel, MD

According to 2025 Medicare claims, Chirag Patel, MD (NPI: 1124224936) practices ophthalmology in the Columbus, OH market, with the plurality of this provider's patient population coming from Franklin, OH. This provider's primary affiliated billing organization is RETINA GROUP, INC (NPI: 1588794200; TIN: 311460051) and primary practice location at 43213-2120.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 787 traditional Medicare patients, billed 17,920 HCPCS/CPT codes, and received $2,493,516 in Medicare payments. The top billing code was J3590 (Unclassified biologics). Part D data shows 796 prescription claims across 217 beneficiaries totaling $32,775 in drug costs, led by Lumigan (Bimatoprost). Open Payments data shows 42 records totaling $806. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $755,155 to $2,493,516. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $15,391 to $32,775. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.2M$2.5M2015 Medicare payment: $755,155 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,017,988 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,197,463 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,373,385 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,318,987 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,665,598 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,824,076 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,981,299 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,267,516 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,493,516 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154494,185$755,155
20164855,315$1,017,988
20176156,468$1,197,463
20187657,500$1,373,385
20196436,630$1,318,987
20209167,761$1,665,598
20219728,540$1,824,076
20228678,974$1,981,299
202386817,718$2,267,516
202478717,920$2,493,516

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$26K$51K2015 Drug cost: $15,391 (USD; Tot_Drug_Cst)2016 Drug cost: $17,086 (USD; Tot_Drug_Cst)2017 Drug cost: $22,134 (USD; Tot_Drug_Cst)2018 Drug cost: $24,710 (USD; Tot_Drug_Cst)2019 Drug cost: $23,880 (USD; Tot_Drug_Cst)2020 Drug cost: $41,452 (USD; Tot_Drug_Cst)2021 Drug cost: $51,141 (USD; Tot_Drug_Cst)2022 Drug cost: $38,636 (USD; Tot_Drug_Cst)2023 Drug cost: $30,398 (USD; Tot_Drug_Cst)2024 Drug cost: $32,775 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015115334$15,391
2016118334$17,086
2017139505$22,134
2018167526$24,710
2019132435$23,880
2020200833$41,452
2021244806$51,141
2022207743$38,636
2023223727$30,398
2024217796$32,775

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J3590Unclassified biologics160409$560
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more156156$115
67028Injection of drug into eye3291,235$88
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more6221,041$58
92134Imaging of retina6831,850$26

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LumiganBimatoprost211,185$9,484
Prednisolone AcetatePrednisolone Acetate2207,328$7,325
Atropine SulfateAtropine Sulfate1023,143$2,872
Brimonidine TartrateBrimonidine Tartrate703,498$2,728
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat453,060$621

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.42$806Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Chirag C. Patel, MD?

Tedicare shows public-source Medicare data for Chirag C. Patel, MD (NPI 1124224936), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Chirag C. Patel, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Chirag C. Patel, MD?

Chirag C. Patel, MD is linked to RETINA GROUP, INC (billing NPI 1588794200) in the available physician profile data.

Does Chirag C. Patel, MD have Open Payments data?

Chirag C. Patel, MD has 42 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.